PANO1
gene geneOn this page
Also known as PANO
Summary
PANO1 (proapoptotic nucleolar protein 1, HGNC:51237) is a protein-coding gene on chromosome 11p15.5, encoding Proapoptotic nucleolar protein 1 (I0J062). Apoptosis-inducing protein that modulates the tumor suppressor function of CDKN2A/p14ARF.
Involved in negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of apoptotic process; and regulation of protein stability. Located in nucleolus.
Source: NCBI Gene 101927423 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 13 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51237 |
| Approved symbol | PANO1 |
| Name | proapoptotic nucleolar protein 1 |
| Location | 11p15.5 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PANO |
| Ensembl gene | ENSG00000288675 |
| Ensembl biotype | protein_coding |
| OMIM | 620541 |
| Entrez | 101927423 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000678030
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000678030 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003904825 | 797511 | 799190 |
Expression profiles
Bgee: expression breadth ubiquitous, 126 present calls, max score 75.43.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.43 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 68.87 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 68.27 | gold quality |
| cerebellum | UBERON:0002037 | 68.24 | gold quality |
| cerebellar cortex | UBERON:0002129 | 68.22 | gold quality |
| stromal cell of endometrium | CL:0002255 | 66.80 | gold quality |
| pituitary gland | UBERON:0000007 | 65.95 | gold quality |
| body of pancreas | UBERON:0001150 | 65.29 | gold quality |
| adenohypophysis | UBERON:0002196 | 64.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 63.44 | gold quality |
| granulocyte | CL:0000094 | 63.08 | gold quality |
| cortical plate | UBERON:0005343 | 63.08 | gold quality |
| primary visual cortex | UBERON:0002436 | 62.84 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 61.83 | gold quality |
| prefrontal cortex | UBERON:0000451 | 61.21 | gold quality |
| right frontal lobe | UBERON:0002810 | 61.21 | gold quality |
| frontal cortex | UBERON:0001870 | 61.12 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 61.05 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 60.67 | gold quality |
| ganglionic eminence | UBERON:0004023 | 60.66 | gold quality |
| cerebral cortex | UBERON:0000956 | 60.47 | gold quality |
| brain | UBERON:0000955 | 60.28 | gold quality |
| pancreas | UBERON:0001264 | 60.17 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 60.10 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 60.10 | gold quality |
| Ammon’s horn | UBERON:0001954 | 59.17 | gold quality |
| temporal lobe | UBERON:0001871 | 58.18 | gold quality |
| amygdala | UBERON:0001876 | 58.02 | gold quality |
| hypothalamus | UBERON:0001898 | 57.56 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 56.76 | gold quality |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- PANO is a new apoptosis-inducing gene by modulating the tumor suppressor protein, p14ARF, and may itself be a new candidate tumor suppressor gene. (PMID:22094112)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Proapoptotic nucleolar protein 1 — I0J062 (reviewed: I0J062)
All UniProt accessions (1): I0J062
UniProt curated annotations — full annotation on UniProt →
Function. Apoptosis-inducing protein that modulates the tumor suppressor function of CDKN2A/p14ARF. Enhances the stability of CDKN2A/p14ARF protein by protecting it from degradation. May act as a tumor suppressor.
Subcellular location. Nucleus. Nucleolus.
Tissue specificity. Widely expressed.
Induction. Up-regulated after serum withdrawal.
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
UniProt features (4 total): region of interest 2, chain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-I0J062-F1 | 51.33 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 29 (showing top):
GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS, GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS, GOBP_REGULATION_OF_PROTEIN_STABILITY, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_REGULATION_OF_PROTEOLYSIS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS, GOBP_PROTEOLYSIS, GOCC_NUCLEOLUS, GOBP_REGULATION_OF_PROTEIN_METABOLIC_PROCESS
GO Biological Process (4): apoptotic process (GO:0006915), regulation of protein stability (GO:0031647), negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435), positive regulation of apoptotic process (GO:0043065)
GO Molecular Function (0):
GO Cellular Component (2): nucleolus (GO:0005730), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| regulation of biological quality | 1 |
| regulation of proteasomal ubiquitin-dependent protein catabolic process | 1 |
| proteasome-mediated ubiquitin-dependent protein catabolic process | 1 |
| negative regulation of proteasomal protein catabolic process | 1 |
| negative regulation of ubiquitin-dependent protein catabolic process | 1 |
| apoptotic process | 1 |
| regulation of apoptotic process | 1 |
| positive regulation of programmed cell death | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
52 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PANO1 | CAAP1 | Q9H8G2 | 367 |
| PANO1 | CDK5R2 | Q13319 | 301 |
| PANO1 | BORA | Q6PGQ7 | 297 |
| PANO1 | ABHD4 | Q8TB40 | 290 |
| PANO1 | GADD45GIP1 | Q8TAE8 | 259 |
| PANO1 | PAPSS1 | O43252 | 255 |
| PANO1 | PAM | P19021 | 245 |
| PANO1 | CENPM | Q9NSP4 | 229 |
| PANO1 | UQCRH | P07919 | 223 |
| PANO1 | CCNK | O75909 | 206 |
| PANO1 | PPA2 | Q9H2U2 | 202 |
| PANO1 | PPP1R10 | Q96QC0 | 200 |
| PANO1 | NFKBID | Q8NI38 | 200 |
| PANO1 | PIDD1 | Q9HB75 | 195 |
| PANO1 | OGT | O15294 | 194 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| INSR | RIMOC1 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A3Q1LFG5, A6NHQ4, A8MZ25, B3EWF7, C0HMD6, H3BQW9, I0J062, I3L1E1, P0C7T7, P0C7V0, P0C864, P0C879, P0C880, P0DP75, P70339, Q495Z4, Q5T4H9, Q5TG53, Q66K80, Q6EEV4, Q6UXQ8, Q6UXU0, Q6ZRN7, Q6ZS46, Q6ZSR3, Q6ZUF6, Q71F78, Q7TNS8, Q86X59, Q8JN06, Q8N319, Q8N6K4, Q8N6U2, Q8N7H1, Q8N7Y1, Q8N910, Q8N9P0, Q8N9X3, Q8NAQ8, Q8NBZ9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 7 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
427 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:797624:C:T | donor_gain | 0.8600 |
| 11:797569:GGG:G | donor_gain | 0.8500 |
| 11:797570:GGG:G | donor_gain | 0.8500 |
| 11:797542:G:GT | donor_gain | 0.8100 |
| 11:798080:G:GT | donor_gain | 0.8000 |
| 11:797628:GGGG:G | donor_gain | 0.7800 |
| 11:797629:GGGG:G | donor_gain | 0.7800 |
| 11:797912:A:AG | donor_gain | 0.7700 |
| 11:798075:TCC:T | donor_gain | 0.7700 |
| 11:797913:A:G | donor_gain | 0.7400 |
| 11:797889:C:T | donor_gain | 0.7200 |
| 11:797940:C:A | donor_gain | 0.7100 |
| 11:798194:G:GT | donor_gain | 0.7100 |
| 11:797990:G:GG | donor_gain | 0.7000 |
| 11:797575:A:AG | donor_gain | 0.6800 |
| 11:797907:C:CA | donor_gain | 0.6800 |
| 11:797921:GT:G | donor_gain | 0.6800 |
| 11:797939:T:TA | donor_gain | 0.6800 |
| 11:797568:AGG:A | donor_gain | 0.6700 |
| 11:797629:GGG:G | donor_gain | 0.6600 |
| 11:797630:GGG:G | donor_gain | 0.6600 |
| 11:798484:C:CA | acceptor_gain | 0.6400 |
| 11:797989:C:G | donor_gain | 0.6300 |
| 11:797911:G:A | donor_gain | 0.6100 |
| 11:797993:T:A | donor_gain | 0.6100 |
| 11:798283:C:T | donor_gain | 0.6100 |
| 11:797576:A:AT | donor_gain | 0.6000 |
| 11:798076:C:A | donor_gain | 0.6000 |
| 11:797630:GG:G | donor_gain | 0.5900 |
| 11:797631:GG:G | donor_gain | 0.5900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000130238 (11:796316 G>C), RS1000896388 (11:798042 G>A,T), RS1001873701 (11:797483 G>A), RS1002172217 (11:797310 G>C), RS1002528290 (11:798342 C>G,T), RS1003543378 (11:799105 C>T), RS1003815885 (11:796532 C>T), RS1004073980 (11:798223 C>G), RS1004177051 (11:799120 T>C), RS1005079417 (11:799091 C>A,G,T), RS1005130311 (11:798845 A>C), RS1005588848 (11:798275 C>G,T), RS1005968005 (11:795906 C>T), RS1006310162 (11:796094 C>T), RS1006922537 (11:797123 G>A)
Disease associations
OMIM: gene MIM:620541 | disease phenotypes: MIM:609304
GenCC curated gene-disease
Mondo (1): developmental and epileptic encephalopathy, 3 (MONDO:0012245)
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): developmental and epileptic encephalopathy, 3